Anti-inflammatory molecules PD-L1 (programmed death ligand -1) and IDO1 (indoleamine-2,3-dioxygenase 1, the enzyme which degrades extracellular tryptophan) are also both markers of GBM cells and EVs, these proteins are upregulated following the treatment of GBM cells with IFN-γ (gamma interferon, key anti-tumor proinflammatory cytokine). The gene discussed is IFNG; the disease is glioblastoma.